Dr Reddy's Laboratories (BSP:R1DY34) 3-Year Share Buyback Ratio : -0.20% (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Dr Reddy's Laboratories 3-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Dr Reddy's Laboratories's current 3-Year Share Buyback Ratio was -0.20%.

The historical rank and industry rank for Dr Reddy's Laboratories's 3-Year Share Buyback Ratio or its related term are showing as below:

BSP:R1DY34' s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -3.2 Med: -0.2 Max: 0.9
Current: -0.2

During the past 13 years, Dr Reddy's Laboratories's highest 3-Year Share Buyback Ratio was 0.90%. The lowest was -3.20%. And the median was -0.20%.

BSP:R1DY34's 3-Year Share Buyback Ratio is ranked better than
71.92% of 673 companies
in the Drug Manufacturers industry
Industry Median: -2.9 vs BSP:R1DY34: -0.20

Competitive Comparison of Dr Reddy's Laboratories's 3-Year Share Buyback Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Dr Reddy's Laboratories's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dr Reddy's Laboratories's 3-Year Share Buyback Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dr Reddy's Laboratories's 3-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Dr Reddy's Laboratories's 3-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Dr Reddy's Laboratories 3-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Dr Reddy's Laboratories (BSP:R1DY34) 3-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Dr Reddy's Laboratories 3-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of Dr Reddy's Laboratories's 3-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr Reddy's Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (BSP:R1DY34) » Definitions » 3-Year Share Buyback Ratio

Traded in Other Exchanges

RDY:USA DRREDDY:India 500124:India RDDA:Germany RDDA:Germany

Address

8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034

Website

https://www.drreddys.com

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Dr Reddy's Laboratories Headlines

No Headlines